Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online June 11, 2007
Diabetes Care 30:2381-2387, 2007
DOI: 10.2337/dc07-0186
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc07-0186v1
30/9/2381    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guize, L.
Right arrow Articles by Benetos, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guize, L.
Right arrow Articles by Benetos, A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cardiovascular and Metabolic Risk
Original Article

All-Cause Mortality Associated With Specific Combinations of the Metabolic Syndrome According to Recent Definitions

Louis Guize, MD1,2, Frédérique Thomas, PHD1, Bruno Pannier, MD1,3, Kathy Bean, MA, MPH1, Bertrand Jego, MBA1 and Athanase Benetos, MD, PHD1,4

1 Centre Investigations Préventives et Cliniques, Paris, France
2 Université Paris-Descartes, Paris, France
3 Hôpital Manhes, Fleury-Merogis, France
4 Centre Hospitalier Universitaire Brabois, Nancy, France

Address correspondence and reprint requests to Prof. Louis Guize, Centre IPC, 6/14 rue La Pérouse, 75116 Paris, France. E-mail: bean{at}ipc.asso.fr

OBJECTIVE—The aim was to evaluate the impact of specific component combinations of the metabolic syndrome on all-cause mortality risk in a large French cohort.

RESEARCH DESIGN AND METHODS—The population was composed of 39,998 men (aged 52.6 ± 8.3 years) and 20,756 women (aged 54.7 ± 9.2 years) who were examined at the Investigations Préventives et Cliniques Center from 1999 to 2002. Mean follow-up was 3.57 ± 1.12 years. Metabolic syndrome was defined according to three definitions: the National Cholesterol Educational Program (NCEP 2001), the revised NCEP (NCEP-R; American Heart Association/National Heart, Lung, and Blood Institute 2005), and the International Diabetes Federation (IDF 2005). Subjects with metabolic syndrome were compared with subjects without metabolic syndrome and with subjects with no metabolic syndrome components using Cox regression models.

RESULTS—The prevalence of metabolic syndrome increased from 10.3% (NCEP) to 17.7% (NCEP-R) and 23.4% (IDF). After adjustment for age, sex, classical risk factors, and socioprofessional categories, and compared with subjects without metabolic syndrome, the risk of all-cause mortality was 1.79 (95% CI 1.35–2.38), 1.46 (1.14–1.88), and 1.32 (1.04–1.67) with the NCEP, NCEP-R, and IDF definitions, respectively. Among the combinations significantly associated with all-cause mortality, the following three-component combinations and the four-component combination were more highly significant than other combinations (P < 0.05): elevated waist circumference plus elevated glucose, plus either elevated blood pressure or elevated triglycerides, and the combination of all four of these.

CONCLUSIONS—In a large middle-aged French population, four specific components of metabolic syndrome are associated with a much higher mortality risk. These results may have a significant impact on detecting high-risk subjects suffering from metabolic disorders and underline the fact that metabolic syndrome is a nonhomogeneous syndrome.

Abbreviations: CHD, coronary heart disease • CVD, cardiovascular disease • DBP, diastolic blood pressure • IDF, International Diabetes Federation • IPC, Investigations Préventives et Cliniques • NCEP, National Cholesterol Educational Program • NCEP-R, revised NCEP • SBP, systolic blood pressure


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Med. Genet.Home page
P Henneman, Y S Aulchenko, R R Frants, K W van Dijk, B A Oostra, and C M van Duijn
Prevalence and heritability of the metabolic syndrome and its individual components in a Dutch isolate: the Erasmus Rucphen Family study
J. Med. Genet., September 1, 2008; 45(9): 572 - 577.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.